These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11800205)

  • 1. Failed attempts at intranasal abuse of Concerta.
    Jaffe SL
    J Am Acad Child Adolesc Psychiatry; 2002 Jan; 41(1):5. PubMed ID: 11800205
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal abuse of prescribed methylphenidate.
    Garland EJ
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):573-4. PubMed ID: 9628076
    [No Abstract]   [Full Text] [Related]  

  • 3. Substance abuse in adolescents: diagnostic issues derived from studies of attention deficit disorder with hyperactivity.
    Loney J
    NIDA Res Monogr; 1988; 77():19-26. PubMed ID: 3145426
    [No Abstract]   [Full Text] [Related]  

  • 4. Attempted abuse of concerta.
    Ciccone PE
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):756. PubMed ID: 12108796
    [No Abstract]   [Full Text] [Related]  

  • 5. Family abuse of methylphenidate.
    Fulton AI; Yates WR
    Am Fam Physician; 1988 Aug; 38(2):143-5. PubMed ID: 3407585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A fatality due to the intranasal abuse of methylphenidate (Ritalin).
    Massello W; Carpenter DA
    J Forensic Sci; 1999 Jan; 44(1):220-1. PubMed ID: 9987890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate euphoria.
    Corrigall R; Ford T
    J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1421. PubMed ID: 8936903
    [No Abstract]   [Full Text] [Related]  

  • 9. Intranasal abuse of prescribed methylphenidate by an alcohol and drug abusing adolescent with ADHD.
    Jaffe SL
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):773-5. PubMed ID: 1938793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attention deficit hyperactivity disorder, facilitating alcohol and drug abuse in an adult].
    Durst R; Rebaudengo-Rosca P
    Harefuah; 1997 May; 132(9):618-22, 680. PubMed ID: 9225572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Student perceptions of methylphenidate abuse at a public liberal arts college.
    Babcock Q; Byrne T
    J Am Coll Health; 2000 Nov; 49(3):143-5. PubMed ID: 11125642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.
    Kuczenski R; Segal DS
    Biol Psychiatry; 2005 Jun; 57(11):1391-6. PubMed ID: 15950013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug dependence and methylphenidate].
    Sora I; Ikari M; Ikeda K
    Seishin Shinkeigaku Zasshi; 2008; 110(10):941-5. PubMed ID: 19278070
    [No Abstract]   [Full Text] [Related]  

  • 18. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of two once-daily methylphenidate formulations compared across dose levels at different times of the day: preliminary indications from a secondary analysis of the COMACS study data.
    Sonuga-Barke EJ; Swanson JM; Coghill D; DeCory HH; Hatch SJ
    BMC Psychiatry; 2004 Sep; 4():28. PubMed ID: 15458569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I.
    Merkel RL; Kuchibhatla A
    Expert Opin Drug Saf; 2009 Nov; 8(6):655-68. PubMed ID: 19785509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.